The eyes are the windows to the brain, and we’re pulling back the curtains. What we find helps optimize the systems that keep our world safe and healthy.
CEO and Chairman of the Board
Herb Meistrich has been a successful leader of companies in venture capital investing, including investments in real estate, hospitality, sports management, service industry delivery, and higher education. Herb has been a principal in the investment of over $500 million of real estate assets, including 30+ hotels and over 40,000 apartment units in 25 states. He has demonstrated success in significantly improving sales and values for new and established businesses through successful marketing, improved operations, expansions, and the restructuring of complicated debt and equity arrangements to enhance value. He has also consulted with major financial institutions to analyze problems involving non-earning assets to establish and implement creative solutions to enhance values.
Herb practiced law for six years from 1966 to 1972. In addition to his venture capital activities, Herb served on the Board of The March of Dimes, the San Diego Zoo and National University and was an Adjunct Professor at NYU. More recently, Herb served as an Expert in Residence at the University of California, Irvine and as a Mentor at the Rady School of Management at the University of California, San Diego.
Herb received a B.A. Degree from Rutgers University, New Brunswick, and an LLB Degree from Columbia University Law School.
President & CTO, Board Member
James Weatherhead joined EyeTracking in 2003 as President, CTO and Board Member. During his tenure, he has led the technical development and commercialization of several of EyeTracking’s key products, including building an international sales team and inventing several of EyeTracking’s key patents.
Prior to EyeTracking, James worked as a Scientist in the Center for Human Sciences and the Defence Evaluation and Research Agency (UK MoD), primarily focusing on advanced human-machine integration with next generation fast jets.
Later he worked as IT Team Leader at QinetiQ , Europe’s largest defense contractor, leading a technical team building fast jet and UAV simulators and prototyping advanced human machine interface concepts, building and prototyping new airport security screening concepts and more.
James received a BSc. (Hons) in Computer Science from the University of Portsmouth (United Kingdom), and is a Chartered Engineer and Chartered IT Professional.
Sandra Marshall, Ph.D.
Chief Science Officer, Board Member
Dr. Sandra Marshall is the Chief Science Officer at EyeTracking LLC. She founded EyeTracking, Inc. (ETI) in 1999 and served as CEO and CSO until ETI became EyeTracking LLC in 2019.
For over three decades, Dr. Marshall has carried out groundbreaking research that examines patterns of individuals’ eye movements and changes in pupil size over extended periods of time. In so doing, she developed and patented several new measures of cognitive activity and engagement. She continues her research efforts today—often in collaborative work with EyeTracking clients who are implementing these measures in applied, real-world settings.
Dr. Marshall also was Professor of Psychology at San Diego State University for more than 20 years, during which time she taught graduate statistics and managed more than 25 government research projects, primarily under DoD support.
Cassandra Davis is the Chief Operating Officer for EyeTracking LLC, a San Diego-based technology company specializing in eye tracking solutions to improve the usability of complex systems and the training of the people that use them. She has been a member of the executive team at EyeTracking since its inception in 1999.
Cassandra has over two decades of experience conducting eye tracking research with the DoD, medical institutions, government agencies, universities, and commercial businesses of all types and sizes all over the world. Before co-founding EyeTracking Inc., she was part of Dr. Sandra Marshall’s research team at San Diego State University as well as a Technical Coordinator for Law Enforcement Online, a nationwide online service to provide law enforcement agencies, criminal justice entities, and intelligence groups access to resources.
Cassandra received a Bachelor of Arts degree in English and Philosophy from the University of Iowa.
Brian Raduenz is the Chief Executive Officer for AEVEX Aerospace, a San Diego-based aerospace and defense company specializing in intelligence solutions. Prior to the formation of AEVEX, he served as CEO of Merlin Global Services, a leading provider of operations, maintenance, and training support to the intelligence community, and one of four companies united to form AEVEX. During the past decade, Brian has led the company through significant organic and acquisition-based growth, while building the infrastructure for a larger platform.
Prior to joining Merlin, Brian served 20 years in the U.S. Air Force as Commander, Flight Test Engineer, and Program Manager supporting a variety of manned and unmanned Intelligence, Surveillance and Reconnaissance (ISR) acquisition programs. He served as Director of White House Presidential Contingency Programs under President George W. Bush.
Brian received a B.S. Degree in Electrical Engineering from the U.S. Air Force Academy, a M.S. Degree in Electrical Engineering from the Air Force Institute of Technology, and a M.S. in Military Studies from Air University.
In 2018, Brian was named “Best Executive – Private Company” by the San Diego Business Journal.
Ann Clare Kessler, PhD
Dr. Ann Clare Kessler started her career at Hoffmann-La Roche, Inc at US Headquarters in New Jersey as Head of the Obesity Program. She was then promoted to Associate Director of Biochemical Nutrition, then to Vice-President and Group Director of Pharmacology and Chemotherapy, and ultimately Vice-President and Head of Drug Discovery and Exploratory Research.
In January 1990, she joined F. Hoffmann-La Roche, Ltd. at Global Headquarters in Basel, Switzerland and created the Global Drug Development System. She later became Head of Global Project Management, and then Head of the Global Portfolio Management Board.
Since retiring from F. Hoffmann-La Roche, Ann has served on several Corporate Boards for Biopharmaceutical and Molecular Diagnostics companies. Ann is currently Vice-Chairman of the Supervisory Board of Epigenomics. During the last five years she has also served as a member of the Boards of Althea Dx, Scripps Translational Science Institute and Medgenesis Therapeutix Inc.
Dr. Ann Clare Kessler received a B.S. Degree in Biology and Biochemistry at Notre Dame University of Maryland, an M.S. Degree in Biochemistry at Northwestern University and a Ph.D. Degree in Biochemistry at New York University.
After 45 years in banking, Rick Chisholm recently retired as a Managing Director and Group Head at Wells Fargo Securities. His team specialized in structuring and underwriting securities for a broad range of educational, cultural, research and other nonprofit clients. Prior to the ten years Rick spent at Wells Fargo, he spent 35 years at Bank of America and BofA Merrill Lynch where he led a variety of teams in municipal securities, international corporate finance, mergers and acquisitions, and global regulatory compliance.
From 1986 until his retirement, Rick specialized in designing and implementing investment banking solutions for both nonprofit and for-profit clients. In total, Rick structured and underwrote over $20 billion of securities.
Rick has been a frequent speaker on the capital markets. Recent groups include the Boston Consortium of Colleges and Universities, the Association of Independent Research Institutes, the Museum Finance Officers Association, the Jesuit College and University Business Officers, the Western Association of College and University Business Officers, and the California Educational Facilities Authority.
Rick received an AB in American History and an MBA in International Finance from UC Berkeley. In addition, he spent one year in graduate school at Columbia University studying international marketing.
Rick currently serves on the boards of National University and the YMCA of San Francisco.
Randy Aliment is a partner in the Seattle office of Lewis Brisbois with a broad-based practice focused on commercial litigation and the higher education and sports industries. He also serves as General Counsel for the Northwest Commission on Colleges and Universities, one of seven regional organizations recognized by the U.S. Department of Education to accredit postsecondary institutions.
Randy has extensive experience representing foreign clients in U.S. litigation and overseeing foreign litigation and commercial transactions for U.S. clients in China, Japan, Canada, Europe, and the Middle East. He is a Foreign Consultant to Duan & Duan, the first privately licensed Chinese law firm, with offices in several cities in China.
Randy has repeatedly been recognized as an outstanding Pacific Northwest lawyer, including: Super Lawyers for Business Litigation, for many years; Best Lawyers in America for Commercial Litigation, 2013 – present; and Who’s Who of International Business Lawyers, 2011 – present.
Stay updated on what’s happening at EyeTracking
Subscribe with your email and get all the latest articles and updated information right to your inbox.